Optimizing treatment with risperidone long acting injections

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Title in English Optimalizace léčby dlouhodobě působící injekcí risperidonu
Authors

ČEŠKOVÁ Eva

Year of publication 2012
Type Article in Periodical
Magazine / Source Acta Psychiatrica Scandinavica
MU Faculty or unit

Central European Institute of Technology

Citation
Doi http://dx.doi.org/10.1111/acps.12014
Field Psychiatry, sexuology
Keywords risperidone; long acting injection; RLAI; treatment
Attached files
Description The outcome could be improved by targeting RLAI treatment at specific patient groups and optimizing the dose. RLAI should be quickly titrated to an effective dose in patients known to be responsive to antipsychotic treatment. The high frequency of co medication in our sample indicates a certain level of pharmacoresistance. In spite of this, a significant decrease in concomitant medication was observed. Therapeutic drug monitoring is another possibility for optimizing treatment with RLAI.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.